Tribulus Terrestris: Clinical Evidence for Testosterone, Libido, and Athletic Performance

Few botanicals have been marketed as aggressively — or as misleadingly — as Tribulus terrestris. Walk into any supplement retailer and you will find bottles promising surging testosterone, restored libido, and gym-ready muscle gains. The clinical literature tells a more complicated, considerably less flattering story. This article works through what the controlled trials actually show, why results disagree so wildly from study to study, and where the honest evidence ends and the marketing begins.

What Tribulus Terrestris Is

Tribulus terrestris, commonly called puncture vine, goat's-head, or caltrop, is a small flowering plant in the Zygophyllaceae family. It grows across the Mediterranean, the Middle East, India, and parts of Africa and Asia. Traditional Ayurvedic medicine has used the fruit (gokshura) for urinary complaints and as a general tonic. Traditional Chinese Medicine has used the same fruit for liver and eye conditions. Bulgarian and Eastern European herbal traditions adopted the plant in the twentieth century, particularly among athletes — which is where its modern reputation as a "testosterone booster" originates.

The compound popularly credited with the plant's effects is protodioscin, a steroidal furostanol saponin. Other saponins present include dioscin, diosgenin, tribulosin, and protogracillin, alongside flavonoids and small amounts of alkaloids. Protodioscin content varies dramatically depending on the part of the plant harvested (fruit, leaf, root), the geographic origin, the growing season, and the extraction method.

Bulgarian Tribulus vs Other Sources

Not all Tribulus is equivalent. Analyses of commercial products have repeatedly shown that protodioscin concentrations can vary by a factor of five or more between brands marketed as the "same" extract. Bulgarian-sourced Tribulus — particularly aerial parts harvested at peak saponin expression — has historically tested higher for protodioscin than Indian, Chinese, or Vietnamese material. The Bulgarian preparation Tribestan, standardised to a stated saponin profile, has been used in several of the more frequently cited clinical trials.

This matters because if a study uses a poorly standardised extract with low saponin content, it is essentially testing a different substance from one using a properly characterised Bulgarian preparation. Much of the conflicting literature can be partially explained by this single variable. For a broader discussion of how plant-origin and extraction affect outcomes, see our adaptogen comparison framework.

Testosterone in Healthy Men: Mostly Negative

The headline claim — that Tribulus raises testosterone — is the claim most poorly supported in eugonadal (normal-testosterone) men.

Neychev & Mitev 2005 J Ethnopharmacol — Tribulus testosterone examined 21 young men (aged 20–36) given a Bulgarian Tribulus extract at 20 mg/kg/day for four weeks. There was no significant change in total testosterone, free testosterone, androstenedione, or luteinising hormone compared with placebo. The authors concluded that Tribulus produced no hormonal effect in healthy young men with already-normal androgen levels.

Rogerson et al. 2007 J Strength Cond Res studied elite rugby players supplemented with 450 mg/day of Tribulus extract during a five-week pre-season strength programme. Again — no change in testosterone, no change in epitestosterone, no change in the testosterone-to-epitestosterone ratio relative to placebo. Subsequent trials including the GamaPro series and analyses in resistance-trained men have largely echoed this finding.

The pattern is consistent: in men whose hormonal axis is already functioning normally, Tribulus does not appear to push testosterone meaningfully upward. For context on what "optimal" actually looks like in a blood panel, see testosterone blood test optimal ranges.

Testosterone in Hypogonadal or Infertile Men: A More Interesting Picture

Where the evidence becomes more genuinely interesting is in men with low or borderline-low testosterone. Small trials in idiopathic infertility and in men with partial androgen deficiency of the ageing male (PADAM) have reported modest but statistically significant increases in total testosterone, improvements in sperm parameters, and improvements in symptom scores. A 2017 trial in hypogonadal men using Tribestan at 750 mg/day for 90 days reported a ~16% increase in total testosterone and meaningful improvement in the Aging Males' Symptoms scale.

The takeaway is consistent with how the body's endocrine feedback works: if the system is already optimised, a botanical secretagogue has little ceiling to push against. If the system is underperforming, modest restoration becomes possible. This same pattern shows up across the herbal androgen literature — see our coverage of Tongkat Ali (Eurycoma longifolia) for a directly comparable case study.

Libido and Sexual Function: The More Favourable Story

Where the Tribulus literature looks genuinely better is sexual function — and the effect appears to operate at least partly independent of measurable testosterone change.

Akhtari et al. 2014 randomised 67 women with hypoactive sexual desire disorder to Tribulus 7.5 mg/day or placebo for four weeks. The Tribulus group showed significant improvements in desire, arousal, lubrication, satisfaction, and pain scores on the Female Sexual Function Index.

Santos et al. 2014 — Santos et al. 2014 Maturitas — Tribulus female sexual function — studied 60 postmenopausal women with sexual dysfunction. The Tribulus group (750 mg/day) showed significant improvement in FSFI domains over placebo. Crucially, free and bioavailable testosterone increased in the treatment group — one of the cleaner positive signals in the entire literature.

Vinarov and colleagues have published several Russian-language trials in women with sexual dysfunction reporting symptomatic improvement, particularly in arousal and lubrication domains.

In men, sexual function trials have produced mixed but generally more favourable results than the testosterone trials. Several small randomised trials in mild-to-moderate erectile dysfunction have reported improved International Index of Erectile Function (IIEF) scores with Tribulus extracts at 1500 mg/day over 12 weeks — improvements that occurred without consistent changes in serum testosterone. This dissociation is one of the more important findings in the field.

Athletic Performance: The Marketing Falls Apart

If Tribulus does not reliably raise testosterone in eugonadal men, it should not reliably build muscle in them — and indeed it doesn't. Across a now-substantial body of resistance-training studies, Tribulus has failed to outperform placebo on measures of strength, lean body mass, body composition, or training adaptations. The Rogerson rugby trial is the cleanest example, but findings have been broadly replicated. Marketing claims of dramatic muscle gain are not supported by controlled evidence in trained or untrained eugonadal men.

For comparison, the Korean red ginseng evidence base shows a similar pattern: small physiological signals, but inconsistent translation to performance outcomes.

Proposed Mechanisms — And Why They Disagree

Two broad mechanistic hypotheses persist in the Tribulus literature.

The first proposes Tribulus as a hormonal secretagogue — that protodioscin upregulates pituitary release of luteinising hormone, which in turn stimulates testicular testosterone production. Animal data partially support this, but the LH-elevation finding has not replicated cleanly in humans.

The second, more nuanced hypothesis, treats Tribulus as an androgen-receptor modulator — that the saponins increase peripheral androgen receptor density or sensitivity, particularly in sexual tissues, producing sexual-function effects without necessarily raising circulating testosterone. This hypothesis fits the observed dissociation between sexual outcomes and hormonal measurements rather better than the secretagogue hypothesis does.

Neither mechanism is fully established. Both remain plausible, and they are not mutually exclusive.

Why Studies Disagree So Wildly

Five factors explain most of the inconsistency:

1. Saponin content varies 5-fold or more between commercial extracts. A "1000 mg Tribulus" capsule from one brand may contain <20 mg of protodioscin; another may contain over 100 mg.
2. Plant part matters. Fruit, leaf, and root extracts have different saponin fingerprints.
3. Dose ranges widely across trials — from 250 mg to 1500 mg/day of extract — with no clear dose-response curve established.
4. Population matters enormously. Eugonadal young men respond differently from hypogonadal older men, who respond differently from postmenopausal women.
5. Outcome measures differ. Testosterone, LH, IIEF, FSFI, 1RM strength, body composition — these are not interchangeable endpoints, and a botanical can be useful for one without affecting the others.

Treating "Tribulus studies" as a uniform body is therefore misleading. The honest reading splits the literature into hormonal effects (mostly null in healthy men, modest in hypogonadal men) and sexual-function effects (more consistently positive across both sexes).

Safety Profile

Tribulus is generally well tolerated. Reported adverse events in clinical trials have been mild and infrequent — gastrointestinal upset, occasional sleep disturbance, mild agitation. There are isolated case reports of more serious effects (hepatotoxicity, gynaecomastia in a single case), and one case of acute kidney injury attributed to a Tribulus-containing supplement in an Australian patient — though contamination or adulteration could not be excluded.

There is a theoretical concern about additive effects with other androgenic or pro-libido agents, and Tribulus should not be combined with anabolic agents or used during pregnancy. Anyone with a history of hormone-sensitive cancer, prostate enlargement, or cardiovascular disease should consult a clinician before use.

How Tribulus Compares to Tongkat Ali

The closest natural-product comparison is Eurycoma longifolia (Tongkat Ali), which has accumulated a notably stronger evidence base in men with stress-related testosterone suppression and in sub-fertile men. Tongkat Ali shows more consistent serum testosterone elevation in lower-testosterone populations than Tribulus does, and arguably better evidence for free-testosterone effects via sex-hormone-binding-globulin modulation. Tribulus has the stronger female sexual-function signal of the two. For a full breakdown, see our Tongkat Ali evidence review and related botanicals like maca root and ashwagandha.

Where Research Compounds Fit

Botanical adaptogens occupy one end of the men's-health research spectrum. At the other end sit peptide and pharmacological research tools — gonadotropin-releasing-hormone analogues, selective androgen-receptor modulator candidates, and other endocrine research compounds used in laboratory settings. Researchers working in this space typically source through a specialist research peptide supplier with verified analytical certificates, rather than from generic supplement channels. The two categories should not be conflated — but understanding both is part of an honest picture of the field.

Honest Assessment

If we strip away the marketing, the defensible reading of the Tribulus literature is this:

• Testosterone in healthy men: No reliable effect. Stop expecting one.
• Testosterone in hypogonadal or sub-fertile men: Modest, biologically plausible effects in some trials; not a substitute for proper clinical management.
• Sexual function in men with mild ED: Modest improvement in several trials, possibly via androgen-receptor modulation rather than hormonal change.
• Sexual function in women, especially postmenopausal: The strongest signal in the entire literature; worth taking seriously.
• Athletic performance: No.
• Product quality: Highly variable. Bulgarian-standardised material with declared protodioscin content is the only rational starting point.

Key Takeaways

• Tribulus terrestris is a saponin-rich botanical whose effects centre on protodioscin and related steroidal saponins.
• Bulgarian-sourced, standardised extracts show more consistent results than poorly characterised material.
• Testosterone-raising claims in healthy men are not supported by controlled trials.
• Sexual-function benefits — especially in women with HSDD and postmenopausal sexual dysfunction — are the most reproducible finding.
• Athletic performance and muscle-gain claims are not supported by the evidence.
• Standardisation is the largest single variable explaining literature disagreement.
• Safety is generally good but not absolute; consult a clinician for any hormone-related use.

The Tribulus story is a useful case study in how a botanical can have some real effects, be marketed for different effects entirely, and end up with a public reputation almost completely disconnected from its actual clinical evidence base.